GT Biopharma Inc. logo

GT Biopharma Inc. (GTBP)

Market Closed
26 Oct, 08:00 PM
NASDAQ (CM) NASDAQ (CM)
$
5. 20
-0.26
-4.7619%
After Hours
$
6. 29
+1.09 +20.9615%
8.87M Market Cap
- P/E Ratio
- Div Yield
9,582 Volume
-10.8 Eps
$ 5.46
Previous Close
Add Transaction
Day Range
5.2 5.42
Year Range
0.22 11.98
Want to track GTBP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

GT Biopharma Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
JD
Jim Dushek HARBOUR INVESTMENTS Inc.
20 $245 $106.8 -$138.2 -56.41%
Donna Rittershausen
Donna Rittershausen Koss-Olinger Consulting LLC
400 $4,900 $2,200 -$2,700 -55.1%
Richard Slavik
Richard Slavik Newbridge Financial Services Group Inc.
150 $970.5 $832.5 -$138 -14.22%
CGL
Chester Gary Lloyd Coston, McIsaac & Partners
683.68 $13,417.22 $3,732.89 -$9,684.33 -72.18%
Vincent Incerto
Vincent Incerto LaSalle St. Investment Advisors LLC
440 $4,488 $2,409 -$2,079 -46.32%
Christopher C. Powers
Christopher C. Powers Farther Finance Advisors, LLC
120 $825 $639.6 -$185.4 -22.47%
KPL
Kitching Partners LLC KITCHING PARTNERS, LLC
2,000 $24,486 $10,920 -$13,566 -55.4%
Dan Wohlgemuth
Dan Wohlgemuth 49 WEALTH MANAGEMENT, LLC
2,560 $31,342.08 $14,080 -$17,262.08 -55.08%
Reyes Financial Architecture Inc.
Reyes Financial Architecture Inc. Reyes Financial Architecture Inc.
25 $306 $133 -$173 -56.54%
William Bradley Clayton
William Bradley Clayton Sagespring Wealth Partners LLC
800 $9,794.4 $4,280 -$5,514.4 -56.3%